Ribbon Acquisition Corp(RIBB) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 17440 | EPS (ttm) | 0 | Insider Own | 27.66% | Shs Outstand | 6.3M | Perf Week | 24.39% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 4.5M | Perf Month | 22.82% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | - | Inst Own | 38.8% | Short Float | 0.02% | Perf Quarter | -19.41% |
| Income | 0.00B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.03 | Perf Half Y | -17.97% |
| Sales | 0.00B | P/B | 205.61 | EPS next 5Y | - | ROA | 0.91% | Short Interest | 0.00M | Perf YTD | -15.99% |
| Book/sh | 0.04 | P/C | - | EPS past 3/5Y | - | ROE | 0.97% | 52W High | -52.79% ($18.47) | Perf Year | -15.26% |
| Cash/sh | 0 | P/FCF | - | Sales past 3/5Y | - | ROIC | 1.26% | 52W Low | 53.79% ($5.67) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 4.63% 14.33% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.94 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0 | EPS Q/Q | -100% | Profit Margin | - | RSI (14) | 60.67 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0 | Sales Q/Q | - | SMA20 | 25.61% ($6.94) | Beta | 0.19 | Target Price | - |
| Payout | - | Debt/Eq | 0.05 | Earnings | - | SMA50 | 3.11% ($8.46) | Rel Volume | 0.22 | Prev Close | $8 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -11.84% ($9.89) | Avg Volume(3M) | 0.03M | Price | $8.72 |
| IPO | 2025/3/7 | Option/Short | No/Yes | Trades | 96 | Volume | 6,204 | Change | 9% |
This is a special purpose acquisition company (SPAC) pursuing a merger with DRC Medicine Ltd., a Japanese healthcare and biotech company.
Over the past 1 year, on the lower side
53% below its 1-year high.
Traded less than usual. That is 22% of its average volume.
Company yardsticks do not fit here, so profitability, valuation and earnings are left out. The other verdicts still apply.
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 38.8%.
Tap to view numbers
It ranks #1341 of 1433 in the industry
Based on market cap of $55M.
FAQ
What kind of company is RIBB?
RIBB belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of RIBB?
The market cap of RIBB is approximately $55M, ranking 4,793 within its sector.
What is the P/E ratio of RIBB?
RIBB has a P/E ratio of approximately 17440.0x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for RIBB?
RIBB has recorded a 52-week high of $18.47 and a low of $5.67.